Table 3.

Participant demographics and species assessed, stratified by region

	Asia		Africa		South and Central America		Oceania		Multi-region		Total
Age of participants (n = 1,022)* (years)
< 5 only	2	1.5%	125	94.0%	0	0.0%	6	4.5%	0	0.0%	133	13.0%
5–15 only	2	14.3%	9	64.3%	0	0.0%	3	21.4%	0	0.0%	14	1.4%
> 15 only	165	67.1%	55	22.4%	22	8.9%	2	0.8%	2	0.8%	246	24.1%
Multiple age categories	299	47.5%	249	39.6%	61	9.7%	9	1.4%	11	1.8%	629	61.5%
Included pregnancy (n = 1,036)	18	32.7%	36	65.5%	0	0.0%	1	1.8%	0	0.0%	55	5.3%
Species (n = 1,040)
P. falciparum†	303	38.5%	426	54.1%	40	5.1%	6	0.8%	12	1.5%	787	75.7%
P. vivax‡	120	67.8%	15	8.5%	37	20.9%	4	2.3%	1	0.6%	177	17.0%
Both§	51	70.8%	3	4.2%	8	11.1%	10	13.9%	0	0.0%	72	6.9%
Other species	3	75.0%	1	25.0%	0	0.0%	0	0.0%	0	0.0%	4	0.4%

P. falciparum = Plasmodium falciparum; P. knowlesi = Plasmodium knowlesi; P. malariae = Plasmodium malariae; P. ovale = Plasmodium ovale; P. vivax = Plasmodium vivax. Percentages are expressed as a proportion of total studies for each row. Percentages in the final column are derived using the number of studies with available data for that variable as the denominator, denoted by n.

^*These are mutually exclusive categories, that is, showing studies that were restricted to each age category.

^†Includes seven studies that also assessed patients with P. malariae and/or P. ovale.

^‡Includes one study that also assessed patients with P. knowlesi.

^§Includes 11 studies that also assessed patients with P. malariae, P. ovale, and/or P. knowlesi.